Skip to main content
Clinical Trials/NCT04314414
NCT04314414
Completed
Not Applicable

Peer Recovery Coaching to Facilitate Comprehensive HCV, HIV and Opioid Use Disorder Treatment: A Pilot Study

Boston Medical Center1 site in 1 country31 target enrollmentDecember 20, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hepatitis C
Sponsor
Boston Medical Center
Enrollment
31
Locations
1
Primary Endpoint
Acceptability of Intervention
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The objective of this study is to determine the feasibility and acceptability of a peer recovery coach (PRC) intervention to improve linkage to hepatitis C (HCV) and/or human immunodeficiency virus (HIV) care, treatment initiation, and evaluation for HIV pre-exposure prophylaxis (PrEP) (when applicable) among individuals with a history of opioid use disorder accessing a substance use low-barrier-to-access (LBA) walk-in clinic.

In-depth interviews will be administered to participants at baseline, three- and six-months for study participants (40 total participants). The investigator will also follow-up with the per recovery coach and administer surveys to assess the feasibility of a peer recovery coaching intervention in improving HCV/HIV related linkage to care and management. Patient medical records and peer recovery coach monthly reports will be accessed and reviewed to determine fidelity to research protocols.

Detailed Description

\*NOTE\* Due to the COVID-19 pandemic, surveys were conducted via telephone and not all participants could be contacted. Therefore, the number of results from participants at three months and six months vary. The data gathered are from participants that were reachable and completed the surveys.

Registry
clinicaltrials.gov
Start Date
December 20, 2020
End Date
January 28, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Individuals with opioid use disorder, non-reactive HIV antibody test and reactive HCV antibody testing at the BMC LBA walk-in clinic
  • Able to speak English
  • Individuals providing contact information of two family members or friends
  • Individuals signing a medical records release form

Exclusion Criteria

  • Individuals already linked to substance use care
  • Individuals co-infected with HIV and HCV and engaged in care

Outcomes

Primary Outcomes

Acceptability of Intervention

Time Frame: 6 months

As part of an investigator developed survey a 5-point LIkert scale question will be asked on how acceptable the intervention/care was where 1 is not acceptable and 5 is very acceptable.

Secondary Outcomes

  • Participant Linkage to HCV Care(6 months)
  • Number of Participants Who Received Pre-exposure Prophylaxis (PrEP)(6 months)
  • Participant Linkage to Care for Opioid Use(3 months and 6 months)
  • Participant Linkage to HIV Care(3 months and 6 months)
  • Number of Participants Who Received HCV Care(6 months)
  • Number of Participants Who Received Opioid Use Treatment(6 months)

Study Sites (1)

Loading locations...

Similar Trials